Tirzepatide is a groundbreaking therapeutic agent for individuals struggling type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://zaynhezw388669.get-blogging.com/40998597/tirzepatide-a-novel-glp-1-and-gip-receptor-agonist